Senior Director, Portfolio Integration Lead

Das ist der Job

We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines.

Darum lohnt es sich

Working closely with both the VP and Clinical Development Leads (CDLs) and cross-functional teams across GSK, this role ensures scientific alignment, portfolio coherence, and development excellence across assets.

This includes bringing clinical context to novel biomarker strategies and trial designs, particularly for early-stage and mechanistically novel assets and across programmes with similar indications. /ppThe position is open to candidates from either a medical or non-medical background based on the expertise required to be successful operating at the intersection of oncology disease strategy, clinical development, and portfolio leadership.br/ /ppbIn This Role You Will: /b /plipProvide senior scientific partnership to CDLs, particularly in areas such as disease biology, biomarker strategy, and novel treatment combinations development. /p /lilipEnsure consistent cross-programme ways of working to improve development efficiency and execution. /p /lilipDrive cross-programme portfolio working groups and ensure business level alignment /p /lilipDrive and support clinical trial innovation based on evolving oncology treatment landscape, government regulations, basic/translational science, and emerging technologies (such as AI-enabled tools). /p /lilipStrengthen the scientific and strategic positioning of a pan-asset portfolio across multiple clinical and pre-clinical assets. /p /lilipDrive initiatives that advance data and technology strategies supporting development decision-making. /p /lilipShape engagement with external experts and governance bodies including advisory boards where relevant. /p /lipbr/bKey Responsibilities /b /ppbPortfolio Strategy Cross-Program Integration /b /plipShape the advancement of multiple development programs within the oncology portfolio by providing scientific insights across assets, ensuring that agreed disease strategy is implemented consistently across programs. /p /lilipPrepare detailed strategic analyses and portfolio recommendations on behalf of the Disease Area Vice President, enabling effective decision-making at senior leadership and governance levels. /p /lilipEnsure alignment and coordination across Clinical Matrix Teams (CMTs) and relevant cross-functional stakeholders in Research Development (RD), Global Medical Affairs (GMA) and Global Product Strategy (GPS). /p /lilipDrive disease-level strategic discussions and portfolio planning, bringing a pan-asset perspective to governance discussions and portfolio prioritization. /p /lilipServe as a subject matter expert supporting global health authority interactions, regulatory submissions and key development milestones across multiple assets. /p /lipbr/bPartnership with Clinical Development Leads /b /plipServe as a scientific thought partner to CDLs across multiple asset programs, shaping key aspects of clinical development strategy for a given tumour types, including: /p /lilipdisease biology and translational science /p /lilipbiomarker and precision medicine approaches /p /lilipcombination strategies /p /lilipemerging clinical development opportunities /p /lipbr/bClinical Development Excellence /b /plipEstablish and champion consistent ways of working across programs to improve efficiency and development quality. /p /lilipDrive innovation in clinical development approaches for a given disease area, including trial design, novel endpoints, and emerging technologies such as AI-enabled analytics where appropriate. /p /lipbr/bExternal Scientific Engagement /b /plipMaintain a deep understanding of the evolving tumour disease landscape, standards of care, and emerging science. /p /lilipShape engagement with external experts through advisory boards. /p /lilipSynthesise portfolio-level external insights to inform and strengthen development strategy across multiple programs. /p /lipbr/bData Innovation Strategy /b /plipDrive initiatives that strengthen the application of data, technology, and analytics in clinical development decision-making for a given tumour type. /p /lilipChampion innovative approaches to clinical trials and portfolio insights, ensuring the tumour portfolio remains at the forefront of emerging capabilities. /p /lipbr/bBasic Qualifications: /b /plipBachelor’s / Master’s / Advanced degree in a scientific or medical discipline.

If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are. /p pbBusiness Introduction /bbr/At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade.

Our RD focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives.

GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success.

We’re uniting science, technology, and talent to get ahead of disease together.br/Find out more:br/ /ppbJob Title: Senior Director, Portfolio Integration Lead /b /ppbr/bOverview /b /ppCancer is unrelenting, but so are we.

At GSK, we are committed to transforming outcomes for people with cancer through innovative science, bold ambition, and strong partnerships across the healthcare ecosystem.

We focus our science where it can matter most - advancing care in cancers with high unmet need, grounded in a deep understanding of disease biology and deliberate scientific choices that connect discovery to meaningful impact in the real world. /ppThe Portfolio Integration Lead (PIL) is a senior role in Oncology Clinical Development, responsible for shaping the advancement of multiple oncology programmes from our portfolio with a focus on particular cancers.

This is a senior individual contributor position that operates across the full breadth of an Oncology portfolio rather than within a single programme, enabling cross-asset integration and strategic alignment across development activities. /ppThe PIL applies a disease-level clinical and scientific lens across the portfolio, integrating disease biology, biomarker strategy, and emerging clinical approaches to define what is scientifically feasible and inform development pathways across programmes.

Candidates may come from a medical or scientific background; oncology drug development expertise with defined experience is expected. /p /lilipExperience in oncology drug development within pharmaceutical or biotechnology environments, including involvement across multiple programs or assets. /p /lilipExperience of clinical development processes, regulatory pathways, and oncology therapeutic landscapes. /p /lilipExperience in operating structured matrix organizations and demonstrate decision-making and stakeholder engagement at senior organizational levels. /p /lipbr/bPreferred Qualifications: /b /plipExperience as a Clinical Development Lead, Medical Director, Clinical Scientist Program Lead, or equivalent program leadership role in oncology. /p /lilipExpertise in biomarker development, precision medicine strategies, or combination therapy approaches. /p /lilipExperience engaging with external scientific experts, advisory groups, and Health Authorities. /p /lilipDemonstrated ability to influence senior stakeholders and shape strategic portfolio discussions. /p /lilipFamiliarity with clinical trial innovation methods, including AI/ML applications, adaptive trial designs, or real-world evidence integration. /p /lipbWork Arrangement: /b This role offers a hybrid working model, with a mix of on-site and remote work.

Remote or fully home-working arrangements are not available for this role. /ppbWhy GSK? /b /ppbUniting science, technology and talent to get ahead of disease together. /b /ppGSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. /ppPeople and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most.

Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people. /ppGSK is an Equal Opportunity Employer.

This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law. /ppWe believe in an agile working culture for all our roles.